Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/17699857

Clin. Cancer Res. 2007 Aug 15 13 16 4795-9

Download in:

View as

General Info

PMID
17699857